课题基金 / 基金详情

项目摘要

项目成果

Warren C LADIGES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The main focus of this proposal is investigation of the concept that functional variation in the DNA repair gene XRCC1 can influence susceptibility to carcinogen-induced tumorigenesis. XRCC1 has been shown to be a key player involved in base excision repair, single strand break repair, and possibly double strand break repair. A number of XRCC1 polymorphisms have been identified, and cancer association studies have received extensive epidemiological attention but with conflicting results. In order to help validate the important biological role of DNA repair and specifically XRCC1, in environmental carcinogenesis we are proposing to use mutant mouse models representing human haploinsufficiency and polymorphisms. XRCC1 has no known enzymatic activity, but depends on protein to protein interactions to carry out its functional role in DNA repair. Therefore, use of a biological system such as the mouse to help define function related to expression of an observable tumor phenotype when challenged with a carcinogen is a major means of investigating XRCC1 function. Azoxymethane (AOM) is an alkylating agent and a well-established carcinogen in mice with a spectrum of pre-tumor, pre-malignant, and malignant lesions in the colon and to a lesser extent the liver. It also serves as a prototype for alkylating agents present in the environment that present potentially significant exposure risks. Our hypothesis is that cancer susceptibility to AOM can be influenced by XRCC1 haploinsufficiency and single nucleotide polymorphisms R194W and R280H. Information generated from our proposed studies could be used to help design clinically relevant studies to identify individuals or groups that may be at increased cancer risk for specific environmental conditions. PUBLIC HEALTH RELEVANCE: The main focus of this proposal is investigation of the concept that functional variation in the DNA repair gene XRCC1 can influence susceptibility to carcinogen-induced tumorigenesis. XRCC1 has been shown to be a key player involved in base excision repair, single strand break repair, and possibly double strand break repair. A number of XRCC1 polymorphisms have been identified, and cancer association studies have received extensive epidemiological attention but with conflicting results. In order to help validate the important biological role of DNA repair and specifically XRCC1, in environmental carcinogenesis we are proposing to use mutant mouse models representing human haploinsufficiency and polymorphisms.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
A model of chronic hepatitis in mice expressing a truncated XRCC1 protein.
表达截短的 XRCC1 蛋白的小鼠慢性肝炎模型。
DOI: 10.3402/pba.v5.27703
发表时间: 2015
期刊: Pathobiology of aging & age related diseases
影响因子: --
作者: [Ge,Xuan, Pettan-Brewer,Christina, Morton,John, Ladiges,WarrenC]
通讯作者: Ladiges,WarrenC
DOI: 10.1093/nar/gkr280
发表时间: 2011-10
期刊: Nucleic acids research
影响因子: 14.9
作者: [McNeill DR, Lin PC, Miller MG, Pistell PJ, de Souza-Pinto NC, Fishbein KW, Spencer RG, Liu Y, Pettan-Brewer C, Ladiges WC, Wilson DM 3rd]
通讯作者: Wilson DM 3rd
Physical resilience is a predictor of healthy aging
  • 批准号:
    10731992
  • 项目类别:
  • 资助金额:
    $67.3万
  • 财政年份:
    2017
  • 负责人:
    Warren C LADIGES
  • 依托单位:
Physical resilience is a predictor of healthy aging in mice
  • 批准号:
    9418968
  • 项目类别:
  • 资助金额:
    $31.78万
  • 财政年份:
    2017
  • 负责人:
    Warren C LADIGES
  • 依托单位:
Physical resilience is a predictor of healthy aging in mice
  • 批准号:
    10166752
  • 项目类别:
  • 资助金额:
    $31.78万
  • 财政年份:
    2017
  • 负责人:
    Warren C LADIGES
  • 依托单位:
Pathology of Aging Research Network
  • 批准号:
    9063461
  • 项目类别:
  • 资助金额:
    $38.63万
  • 财政年份:
    2014
  • 负责人:
    Warren C LADIGES
  • 依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    郑巧
  • 依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    陈立达
  • 依托单位: